NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome
Vancheswaran Gopalakrishnan(AstraZeneca (United States)), Glenda Lassi(AstraZeneca (United Kingdom)), Christopher Morehouse, Maria G. Belvisi(Lung Institute), Carolina Caceres(AstraZeneca (United States)), Antonio DiGiandomenico(AstraZeneca (South Korea)), Karl J. Staples(University Hospital Southampton NHS Foundation Trust), Tara Kenny(United States Army Medical Research Institute of Infectious Diseases), Arnita Barnes(AstraZeneca (United States)), Ventzislava A. Hristova(AstraZeneca (United States)), Jérôme Bouquet(University of California, San Francisco), Kristoffer Ostridge(Southampton General Hospital), Lisa Öberg(AstraZeneca (Sweden)), Alexey Ruzin(AstraZeneca (United States)), Natalie R. van Zuydam(AstraZeneca (United States)), Matthew S. Glover, Michael Hühn(AstraZeneca (Sweden)), Susan J. Wilson(Health Canada), Steven Novick(Quantitative BioSciences), Paul Warrener(AstraZeneca (United States)), Christine Tkaczyk(AstraZeneca (France)), Bret R. Sellman(AstraZeneca (United States)), Daniel Muthas(AstraZeneca (Sweden)), Raghothama Chaerkady(Johns Hopkins University), Christopher McCrae(AstraZeneca (United States)), Margaret Kehl(AstraZeneca (United States)), Tom Wilkinson(University Hospital Southampton NHS Foundation Trust), Tianhui Zhang(Chinese Academy of Sciences), Sonja Hess(Western Human Nutrition Research Center), B. Angermann(AstraZeneca (Sweden)), Adam Platt(AstraZeneca (United Kingdom)), Junmin Wang(Quantitative BioSciences), Jung Hwan Kim(AstraZeneca (United States)), Harini Shandilya(AstraZeneca (United States)), Ben Sparklin(AstraZeneca (United States)), Bairu Zhang
Cited by 4
Related Papers
A draft map of the human proteome
|Nature|2014|2.3k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k